Cargando…

Tumor Location Causes Different Recurrence Patterns in Remnant Gastric Cancer

PURPOSE: Tumor recurrence is the principal cause of poor outcomes in remnant gastric cancer (RGC) after resection. We sought to elucidate the recurrent patterns according to tumor locations in RGC. MATERIALS AND METHODS: Data were collected from the Shanghai Cancer Center between January 2006 and De...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Bo, Zhang, Haixian, Wang, Jiangli, Cai, Hong, Xuan, Yi, Xu, Dazhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Gastric Cancer Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633930/
https://www.ncbi.nlm.nih.gov/pubmed/36316111
http://dx.doi.org/10.5230/jgc.2022.22.e29
_version_ 1784824351754813440
author Sun, Bo
Zhang, Haixian
Wang, Jiangli
Cai, Hong
Xuan, Yi
Xu, Dazhi
author_facet Sun, Bo
Zhang, Haixian
Wang, Jiangli
Cai, Hong
Xuan, Yi
Xu, Dazhi
author_sort Sun, Bo
collection PubMed
description PURPOSE: Tumor recurrence is the principal cause of poor outcomes in remnant gastric cancer (RGC) after resection. We sought to elucidate the recurrent patterns according to tumor locations in RGC. MATERIALS AND METHODS: Data were collected from the Shanghai Cancer Center between January 2006 and December 2020. A total of 129 patients with RGC were included in this study, of whom 62 had carcinomas at the anastomotic site (group A) and 67 at the non-anastomotic site (group N). The clinicopathological characteristics, surgical results, recurrent diseases, and survival were investigated according to tumor location. RESULTS: The time interval from the previous gastrectomy to the current diagnosis was 32.0±13.0 and 21.0±13.4 years in groups A and N, respectively. The previous disease was benign in 51/62 cases (82.3%) in group A and 37/67 cases (55.2%) in group N (P=0.002). Thirty-three patients had documented sites of tumor recurrence through imaging or pathological examinations. The median time to recurrence was 11.0 months (range, 1.0–35.1 months). Peritoneal recurrence occurred in 11.3% (7/62) of the patients in group A versus 1.5% (1/67) of the patients in group N (P=0.006). Hepatic recurrence occurred in 3.2% (2/62) of the patients in group A versus 13.4% (9/67) of the patients in group N (P=0.038). Patients in group A had significantly better overall survival than those in group N (P=0.046). CONCLUSIONS: The tumor location of RGC is an essential factor for predicting recurrence patterns and overall survival. When selecting an optimal postoperative follow-up program for RGC, physicians should consider recurrent features according to the tumor location.
format Online
Article
Text
id pubmed-9633930
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Korean Gastric Cancer Association
record_format MEDLINE/PubMed
spelling pubmed-96339302022-11-14 Tumor Location Causes Different Recurrence Patterns in Remnant Gastric Cancer Sun, Bo Zhang, Haixian Wang, Jiangli Cai, Hong Xuan, Yi Xu, Dazhi J Gastric Cancer Original Article PURPOSE: Tumor recurrence is the principal cause of poor outcomes in remnant gastric cancer (RGC) after resection. We sought to elucidate the recurrent patterns according to tumor locations in RGC. MATERIALS AND METHODS: Data were collected from the Shanghai Cancer Center between January 2006 and December 2020. A total of 129 patients with RGC were included in this study, of whom 62 had carcinomas at the anastomotic site (group A) and 67 at the non-anastomotic site (group N). The clinicopathological characteristics, surgical results, recurrent diseases, and survival were investigated according to tumor location. RESULTS: The time interval from the previous gastrectomy to the current diagnosis was 32.0±13.0 and 21.0±13.4 years in groups A and N, respectively. The previous disease was benign in 51/62 cases (82.3%) in group A and 37/67 cases (55.2%) in group N (P=0.002). Thirty-three patients had documented sites of tumor recurrence through imaging or pathological examinations. The median time to recurrence was 11.0 months (range, 1.0–35.1 months). Peritoneal recurrence occurred in 11.3% (7/62) of the patients in group A versus 1.5% (1/67) of the patients in group N (P=0.006). Hepatic recurrence occurred in 3.2% (2/62) of the patients in group A versus 13.4% (9/67) of the patients in group N (P=0.038). Patients in group A had significantly better overall survival than those in group N (P=0.046). CONCLUSIONS: The tumor location of RGC is an essential factor for predicting recurrence patterns and overall survival. When selecting an optimal postoperative follow-up program for RGC, physicians should consider recurrent features according to the tumor location. The Korean Gastric Cancer Association 2022-10 2022-09-23 /pmc/articles/PMC9633930/ /pubmed/36316111 http://dx.doi.org/10.5230/jgc.2022.22.e29 Text en Copyright © 2022. Korean Gastric Cancer Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Sun, Bo
Zhang, Haixian
Wang, Jiangli
Cai, Hong
Xuan, Yi
Xu, Dazhi
Tumor Location Causes Different Recurrence Patterns in Remnant Gastric Cancer
title Tumor Location Causes Different Recurrence Patterns in Remnant Gastric Cancer
title_full Tumor Location Causes Different Recurrence Patterns in Remnant Gastric Cancer
title_fullStr Tumor Location Causes Different Recurrence Patterns in Remnant Gastric Cancer
title_full_unstemmed Tumor Location Causes Different Recurrence Patterns in Remnant Gastric Cancer
title_short Tumor Location Causes Different Recurrence Patterns in Remnant Gastric Cancer
title_sort tumor location causes different recurrence patterns in remnant gastric cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633930/
https://www.ncbi.nlm.nih.gov/pubmed/36316111
http://dx.doi.org/10.5230/jgc.2022.22.e29
work_keys_str_mv AT sunbo tumorlocationcausesdifferentrecurrencepatternsinremnantgastriccancer
AT zhanghaixian tumorlocationcausesdifferentrecurrencepatternsinremnantgastriccancer
AT wangjiangli tumorlocationcausesdifferentrecurrencepatternsinremnantgastriccancer
AT caihong tumorlocationcausesdifferentrecurrencepatternsinremnantgastriccancer
AT xuanyi tumorlocationcausesdifferentrecurrencepatternsinremnantgastriccancer
AT xudazhi tumorlocationcausesdifferentrecurrencepatternsinremnantgastriccancer